Breast cancer and bone metastases: a call for appropriate treatment

被引:0
作者
Diana Lüftner
Daniela Niepel
机构
[1] Charité—Universitätsmedizin Berlin,
[2] Amgen (Europe) GmbH,undefined
来源
Supportive Care in Cancer | 2016年 / 24卷
关键词
Bone metastases; Bone-targeted agents; Breast cancer; SREs; Treatment;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:4075 / 4077
页数:2
相关论文
共 141 条
[11]  
de Boer RH(2015)Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer Support Care Cancer 24 447-511
[12]  
Lichinitser M(2013)Long-term treatment with intravenous bisphosphonates in metastatic breast cancer: a retrospective study Breast J 19 504-538
[13]  
Fujiwara Y(2013)Treatment of bone metastases before the onset of pain Int J Clin Oncol 18 531-838
[14]  
Yardley DA(2015)Bone targeting agent treatment patterns and the impact of bone metastases on patients with advanced breast cancer in the US J Clin Oncol 33 A93-undefined
[15]  
Viniegra M(2013)Pain outcomes in patients with advanced breast cancer and bone metastases: results from a randomized, double-blind study of denosumab and zoledronic acid Cancer 119 832-undefined
[16]  
Fan M(undefined)undefined undefined undefined undefined-undefined
[17]  
Jiang Q(undefined)undefined undefined undefined undefined-undefined
[18]  
Dansey R(undefined)undefined undefined undefined undefined-undefined
[19]  
Jun S(undefined)undefined undefined undefined undefined-undefined
[20]  
Braun A(undefined)undefined undefined undefined undefined-undefined